JULIA JORDAN: Open Payments
NPI 1215362421 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 4 payments from 3 companies in 2025. Trend: 2023 $405 · 2024 $44 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $127 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 1 | $28 |
Products named: CAPLYTA, REXULTI, Auvelity.
Industry payments across DE — which companies pay providers there.
